U.S. Health Secretary Halts Enforcement on Six Unapproved Peptides

U.S. Health Secretary Halts Enforcement on Six Unapproved Peptides

健康 政治
登录后即可置顶此事件

U. S. Health Secretary Robert F. Kennedy Jr. announced on October 28 in Washington, D.

C. , that the Department of Health and Human Services will cease enforcement against the sale of six compounded peptide drugs, despite FDA safety warnings. The announcement follows a temporary enforcement discretion the department granted earlier in the week, stating it would not pursue legal action against compounding pharmacies that produce the six peptides while a formal rule change is pending. Most FDA scientific staff had previously voiced opposition to the proposal, citing concerns about the compounds' safety.

参与者

U.S. Department of Health and Human Services Emily Hilliard Dr. Peter Lurie Shabbir Safdar Medivant Healthcare

地点

Washington, D.C., United States

文章

2026年十月29日
1 篇总计
RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them
RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them

The Independent • 10月29日 00:39

Robert F. Kennedy Jr. announced a policy that will stop enforcement against the sale of six compounded peptide compounds, despite FDA warnings about their safety.

可信度 68% 操纵 12% 中立
2026年十月28日
4 篇总计
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides

NPR • 10月28日 22:26

The Department of Health and Human Services announced a policy allowing 503A compounding pharmacies to prepare six peptides that have not received FDA approval, sparking debate over safety and supply.

可信度 73% 操纵 10% 中立
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA

Ars Technica • 10月28日 22:17

Robert F. Kennedy, the U.S. Health Secretary, announced a policy that stops HHS from enforcing against compounding pharmacies that produce six specific peptide substances, despite FDA scientists’ safety concerns.

可信度 55% 操纵 45% 左派
FDA scientists opposed Trump administration’s move to ease peptide access
FDA scientists opposed Trump administration’s move to ease peptide access

The Guardian • 10月28日 18:35

Most FDA scientific staff opposed a Health and Human Services proposal that would limit enforcement against specialty pharmacies selling unapproved peptide drugs, citing safety concerns.

可信度 68% 操纵 25% 中立
RFK Jr. takes shortcut to make some peptides more widely available
RFK Jr. takes shortcut to make some peptides more widely available

NBC News • 10月28日 16:13

The Department of Health and Human Services will not pursue legal action against compounding pharmacies that produce six specific peptides while a formal rule change is pending.

可信度 78% 操纵 30% 中立

相关事件